ピラマル・ファーマ・ソリューションズと味の素バイオファーマサービスは、基本的に一つのことを目的とした提携を発表しました。抗体薬物複合体医薬品の早期開発から実際の商業化までの期間を短縮することです。
Nxera Pharma Co., Ltd. announces two new appointments to its Leadership team:…
Chaperon Inc. will begin offering a new service, "Shaperon Materials Review AI…
GE HealthCare Technologies Inc. has bought the last 50% of Nihon Medi-Physics…
SAP Japan Co., Ltd. announced that Daiichi Sankyo Co., Ltd. has adopted…
MeDiCU Inc., which provides the world's largest emergency and intensive care database…
LPIXEL Inc. has begun business collaboration with Software Service Co., Ltd. By…
Eisai Co., Ltd. announced that it has signed a license agreement with…
Nxera Pharma Co., Ltd. announces two new appointments to its Leadership team:…
Chaperon Inc. will begin offering a new service, "Shaperon Materials Review AI…
GE HealthCare Technologies Inc. has bought the last 50% of Nihon Medi-Physics…
SAP Japan Co., Ltd. announced that Daiichi Sankyo Co., Ltd. has adopted…
MeDiCU Inc., which provides the world's largest emergency and intensive care database…
LPIXEL Inc. has begun business collaboration with Software Service Co., Ltd. By…
Eisai Co., Ltd. announced that it has signed a license agreement with…
アカウントにサインインする